Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout-Reference-Cited by-同舟云学术

Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout

Published:2019-05-31 Issue:3 Volume:106 Page:652-660
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Hill‐McManus Daniel¹,Marshall Scott²,Soto Elena²,Hughes Dyfrig A.¹

Affiliation:

1. Centre for Health Economics and Medicines Evaluation Bangor University Bangor UK

2. Pharmacometrics Pfizer Ltd Sandwich UK

Funder

European Regional Development Fund

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1454

Reference50 articles.

1. Impact of Non-Adherence and Flare Resolution on the Cost-Effectiveness of Treatments for Gout: Application of a Linked Pharmacometric/Pharmacoeconomic Model

2. Translating Pharmacometrics to a Pharmacoeconomic Model of COPD

3. Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease: Cross-Model Comparison of Hypothetical Treatment Scenarios

4. Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals

5. Prediction of Diltiazem Plasma Concentration Curves From Limited Measurements Using Compliance Data

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient‐Led Urate Self‐Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study;ACR Open Rheumatology;2024-04-09

2. Clinical interventions to improve adherence to urate-lowering therapy in patients with gout: a systematic review;International Journal of Pharmacy Practice;2022-04-13

3. Linked Pharmacometric‐Pharmacoeconomic Modeling and Simulation in Clinical Drug Development;Clinical Pharmacology & Therapeutics;2020-10-26

4. Incorporating Pharmacometrics into Pharmacoeconomic Models: Applications from Drug Development;PharmacoEconomics;2020-07-31